Countries: Global Scope
Partners: Reproductive Health Supplies Coalition (RHSC) and USAID
Project Dates: 2017, Ongoing
The objective of this work was to address the need for one, easy-to-navigate online platform to facilitate the dissemination and sharing of global health knowledge. WDI partnered with the Reproductive Health Supplies Coalition (RHSC) and USAID to develop a large open-access collection of global health market literature. With colleagues from RHSC and USAID, we designed and developed the website, conducted literature searches to source content and engaged contributors and users across the global health community. This knowledge-sharing platform will increase returns on donor and other stakeholder-funded research and help advance global health objectives.
Countries: Global Scope
Project Dates: Completed in 2015
The objective of this assignment, funded by the Bill & Melinda Gates Foundation (Gates Foundation) was to inform global artemisinin supply strategy, accounting for malaria elimination strategies for over 30 countries, over a 20+ year time horizon. Artemisinin-based combination therapies (ACTs) are the most effective medicines for malaria, which persists as a global health challenge despite tremendous progress over the last several years. ACTs require artemisinin, derived from Artemisia annua, which is agriculturally produced and can be subject to supply instability.
WDI utilized a scenario-based forecasting methodology to develop demand scenarios and estimate the theoretical size of the artemisinin market by considering countries with differing malaria burdens, treatment policies, funding and intervention strategies, in addition to other malaria elimination-related assumptions. Our work provided the Gates Foundation and their partners with key insights to develop a forward-looking artemisinin supply strategy.
Countries : India, Kenya, Madagascar, Malawi, Zambia
Project Dates: September 2016 – February 2017
The objective of this project was to assess the market conditions for pregnancy tests in both public and private sectors for five selected countries and to determine whether market shaping could be used to improve access to both pregnancy tests and hormonal family planning (FP) methods. This assessment was part of the SHOPS Plus project, which engages the private sector to improve health outcomes in FP and other health areas. Studies suggest that making pregnancy tests more widely available can increase the same-day start of contraception for women seeking FP services, reducing delay and client drop-off.
To meet the objective, WDI worked with Abt Associates and in-country consultants to collect information on pregnancy test markets such as availability, price, quality perceptions, and provider behavior. We then analyzed the findings using USAID market shaping framework and a consultative process to identify the most promising interventions for each country. This analysis provided USAID with strategic recommendations for the local conditions within each country which formed the basis for consultation and planning with USAID country mission teams.
Partners: Concept Foundation
Project Dates: February 2015 – October 2015
Availability of high quality, affordable contraceptive products is critical to global efforts to increase reproductive health access and choice for women in developing countries. The objective of this project was to improve visibility into global demand for the injectable contraceptive depot medroxyprogesterone (DMPA) and to help guide generic DMPA manufacturers’ market entry strategy. DMPA manufacturers were considering investment in international quality assurance (IQA) status and sought to understand future trends in the global IQA-accessible market, much of which is donor-funded in low-and middle-income countries.
To provide visibility into DMPA demand trends, WDI developed a forecasting methodology adapted specifically to the DMPA market’s unique data environment. We combined a market-sizing approach based on recent historical shipment data with a long-term demographic trends projection based on global Demographic and Health Survey (DHS) data, employing several modeling techniques to mitigate data weaknesses and effectively merge the two approaches & data sources. The resulting forecast provided strategic support for generic manufacturer entry into the IQA-accessible market. WDI’s forecasting methodology was adopted by a key reproductive health donor and partner coalition to aid in future contraceptive procurement planning.